These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Determination of the therapeutic activity of caspofungin compared with the amphotericin B in an animal experimental model of histoplasmosis in hamster (Mesocrisetus auratus). Finquelievich J; Landaburu MF; Pinoni V; Iovannitti CA Rev Iberoam Micol; 2011; 28(4):155-8. PubMed ID: 21473926 [TBL] [Abstract][Full Text] [Related]
26. Systemic histoplasmosis with oesophageal obstruction due to Histoplasma granulomas. Successful treatment with rifampicin and amphotericin B. Hull PR S Afr Med J; 1979 Apr; 55(16):639-40. PubMed ID: 462280 [TBL] [Abstract][Full Text] [Related]
28. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection. Haynes RR; Connolly PA; Durkin MM; LeMonte AM; Smedema ML; Brizendine E; Wheat LJ J Infect Dis; 2002 Jun; 185(12):1830-2. PubMed ID: 12085335 [TBL] [Abstract][Full Text] [Related]
29. Combined therapy with amphotericin B and caspofungin in an experimental model of disseminated histoplasmosis. Rodríguez-Arellanes G; Taylor ML; Pérez-Torres A; Curiel-Quesada E; Vargas-Mendoza CF; Martínez-Rivera MA Rev Invest Clin; 2009; 61(1):4-10. PubMed ID: 19507469 [TBL] [Abstract][Full Text] [Related]
30. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Wheat LJ; Connolly-Stringfield P; Blair R; Connolly K; Garringer T; Katz BP; Gupta M Am J Med; 1992 Feb; 92(2):153-60. PubMed ID: 1543199 [TBL] [Abstract][Full Text] [Related]
31. Conditions associated with relapse of amphotericin B-treated disseminated histoplasmosis. Bradsher RW; Alford RH; Hawkins SS; Spickard WA Johns Hopkins Med J; 1982 Apr; 150(4):127-31. PubMed ID: 6278196 [TBL] [Abstract][Full Text] [Related]
32. Progressive disseminated histoplasmosis as seen in adults. Md State Med J; 1971 Feb; 20(2):77-8. PubMed ID: 5141511 [No Abstract] [Full Text] [Related]
33. African histoplasmosis in Eastern Nigeria: report of two culturally proven cases treated with septrin and amphotericin B. Egere JU; Gugnani HC; Okoro AN; Suseelan AV J Trop Med Hyg; 1978 Nov; 81(11):225-9. PubMed ID: 731765 [TBL] [Abstract][Full Text] [Related]
34. Cerebral histoplasmosis in the azole era: report of four cases and review. Saccente M; McDonnell RW; Baddour LM; Mathis MJ; Bradsher RW South Med J; 2003 Apr; 96(4):410-6. PubMed ID: 12916564 [TBL] [Abstract][Full Text] [Related]
35. Therapy for severe histoplasmosis: what's best? Joseph Wheat L Clin Infect Dis; 2004 Feb; 38(3):463-4. PubMed ID: 14727229 [No Abstract] [Full Text] [Related]
39. Experimental chemotherapy of histoplasmosis in nude mice. Williams DM; Graybill JR; Drutz DJ Am Rev Respir Dis; 1979 Oct; 120(4):837-42. PubMed ID: 507510 [TBL] [Abstract][Full Text] [Related]
40. Amphotericin B therapy in the treatment of presumed Histoplasma chorioretinitis: a further appraisal. Giles CL; Falls HF Trans Am Ophthalmol Soc; 1967; 65():136-45. PubMed ID: 6080171 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]